𝙄𝙉𝘼𝘼𝙌𝘾 ᴮᴼ, Route de Lennik 804, Brussels (2025)

03/09/2025

𝐑𝐞𝐯𝐢𝐬𝐢𝐭𝐢𝐧𝐠 𝐇𝐃𝐋 𝐋𝐢𝐩𝐨𝐩𝐫𝐨𝐭𝐞𝐢𝐧 𝐂𝐡𝐨𝐥𝐞𝐬𝐭𝐞𝐫𝐨𝐥 𝐢𝐧 𝐂𝐚𝐫𝐝𝐢𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐃𝐢𝐬𝐞𝐚𝐬𝐞
In this review, we focus on HDL metabolism and delve into the relationship between HDL and CVD, exploring the functions of HDL and the alterations observed in its functions in disease. Taken together, the results analyzed in this article support the conventional wisdom that “too much of a good thing is not always a good thing.” Therefore, we recommend that careful reconsideration of the impact of elevated HDL levels is warranted, and that this topic should be addressed in future research.

( )

► 𝐎𝐫𝐢𝐠𝐢𝐧𝐚𝐥 𝐬𝐨𝐮𝐫𝐜𝐞: Al Zein M, Khazzeka A, El Khoury A, et al., Revisiting high-density lipoprotein cholesterol in cardiovascular disease: ¿Is too much of a good thingalways a good thing?, Progress in Cardiovascular Diseases, Volume 87, 2024, Pages 50-59, ISSN 0033-0620, https://doi.org/10.1016/ j.pcad.2024.10.009.
(https://www.sciencedirect.com/science/article/pii/S0033062024001464)
► 𝗦𝗲𝗰𝗼𝗻𝗱𝗮𝗿𝘆 𝘀𝗼𝘂𝗿𝗰𝗲: https://www.inaaqc.org/2025_asobat

03/09/2025

𝐑𝐞𝐯𝐢𝐬𝐚𝐧𝐝𝐨 𝐞𝐥 𝐜𝐨𝐥𝐞𝐬𝐭𝐞𝐫𝐨𝐥 𝐝𝐞 𝐥𝐢𝐩𝐨𝐩𝐫𝐨𝐭𝐞í𝐧𝐚𝐬 𝐝𝐞 𝐇𝐃𝐋 𝐞𝐧 𝐥𝐚𝐬 𝐞𝐧𝐟𝐞𝐫𝐦𝐞𝐝𝐚𝐝𝐞𝐬 𝐜𝐚𝐫𝐝𝐢𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫𝐞𝐬
En esta revisión, se centran en el metabolismo de HDL y profundizan en la relación entre HDL y ECV, explorando las funciones de HDL y las alteraciones observadas en sus funciones en la enfermedad. En conjunto, los resultados analizados en este artículo respaldan la creencia convencional de que “demasiado de algo bueno no siempre es algo bueno”. Por lo tanto, la recomendación es que se justifica una reconsideración cuidadosa del impacto de los niveles elevados de HDL-C, y que este tema debería revisarse en futuras investigaciones.

( )

► 𝐎𝐫𝐢𝐠𝐢𝐧𝐚𝐥 𝐬𝐨𝐮𝐫𝐜𝐞: Al Zein M, Khazzeka A, El Khoury A, et al., Revisiting high-density lipoprotein cholesterol in cardiovascular disease: ¿Is too much of a good thingalways a good thing?, Progress in Cardiovascular Diseases, Volume 87, 2024, Pages 50-59, ISSN 0033-0620, https://doi.org/10.1016/ j.pcad.2024.10.009.
(https://www.sciencedirect.com/science/article/pii/S0033062024001464)
► 𝗦𝗲𝗰𝗼𝗻𝗱𝗮𝗿𝘆 𝘀𝗼𝘂𝗿𝗰𝗲: https://www.inaaqc.org/2025_asobat

03/09/2025

𝗚𝗼𝗼𝗱 𝗴𝗿𝗶𝗲𝗳, 𝗖𝗵𝗮𝗿𝗹𝗶𝗲 𝗕𝗿𝗼𝘄𝗻! 𝗗𝗼𝗻'𝘁 𝘄𝗮𝘀𝘁𝗲 𝘁𝗵𝗼𝘀𝗲 𝟱 𝗰𝗲𝗻𝘁𝘀
An internet quiz -- falsely attributed to "Peanuts" creator Charles Schulz -- can help you quickly identify your priorities as a leader, presenting factual questions that are tough to answer, such as "Name the last five winners of the Miss America pageant," contrasted with more meaningful questions, such as "Name five people who have taught you something worthwhile," writes Skip Prichard. "Be the person who supports, encourages, and elevates others. That's the kind of leader who leaves a mark that no accomplishment rivals," Prichard notes.

&

► 𝗦𝗼𝘂𝗿𝗰𝗲: https://skipprichard.com/life-lessons-from-a-misattributed-quiz/
-------------------------------------------
✔𝗖𝗔𝗟𝗘𝗡𝗗𝗔𝗥: https://www.inaaqc.org/calendar_2025

03/09/2025

¡𝗖𝗮𝗿𝗮𝗺𝗯𝗮, 𝗖𝗵𝗮𝗿𝗹𝗶𝗲 𝗕𝗿𝗼𝘄𝗻! 𝗡𝗼 𝗺𝗮𝗹𝗴𝗮𝘀𝘁𝗲𝘀 𝗲𝘀𝗼𝘀 𝟱 𝗰𝗲𝗻𝘁𝗮𝘃𝗼𝘀.
Un cuestionario en internet, falsamente atribuido a Charles Schulz, creador de "Peanuts", puede ayudarte a identificar rápidamente tus prioridades como líder, presentando preguntas objetivas difíciles de responder, como "Nombra a las últimas cinco ganadoras del concurso Miss América", en contraste con preguntas más significativas, como "Nombra cinco personas que te hayan enseñado algo valioso", escribe Skip Prichard. "Sé la persona que apoya, anima y eleva a los demás. Ese es el tipo de líder que deja una huella que ningún logro iguala", señala Prichard.

&

► 𝗦𝗼𝘂𝗿𝗰𝗲: https://skipprichard.com/life-lessons-from-a-misattributed-quiz/
-------------------------------------------
✔𝗖𝗔𝗟𝗘𝗡𝗗𝗔𝗥: https://www.inaaqc.org/calendar_2025

02/09/2025

𝗝𝐨𝐮𝐫𝐧𝐚𝐥 𝗥𝐞𝐯𝐢𝐞𝐰 (𝐉𝐑)
----------------------------------------------
Performed on: Friday, July 4, 2025
𝟐𝟎𝟐𝟓 𝐍𝐄𝐉𝐌𝐣𝐰 - 𝐇𝐨𝐰 𝐀𝐜𝐜𝐮𝐫𝐚𝐭𝐞 𝐈𝐬 𝐁𝐌𝐈 𝐚𝐬 𝐚 𝐌𝐞𝐚𝐬𝐮𝐫𝐞 𝐨𝐟 𝐎𝐛𝐞𝐬𝐢𝐭𝐲 (𝐉𝐀𝐌𝐀).𝐩𝐝𝐟
Codified by 𝙄𝙉𝘼𝘼𝙌𝘾 ᴮᴼ (ABFL)

1. 𝙄𝙌𝘾 BS ➩ Y, J, C ➖ T ➕ N ➕ t ➖ P I C O:
2. 𝙄𝙌𝘾 BS 🟰 2025, JAMA, US ➖ survey data ➕ >2k (39yo) ➕ 2017-2018 ➖ P I C O:
- P: adults
- 🅸: excess adiposity = ‘waist circumference + DEXA’ scan
- 🅲: BMI
- O: pOC = concordance
3. EVIDENCE.
- BMI does not distinguish between FAT 🆚 MUSCLE 🆚 BONE
- Concern in some populations like athletes.
4. METHODS.
- Obesity = BMI ≥30 (≥27,5 in non-Hispanic Asians)
- Waist circumference ≥102cm in ♂ (except in non-Hispanic Asians)
- DEXA scanning ≥35% in ♀

𝗩𝗲𝗿 𝗺á𝘀 𝗲𝗻: https://www.inaaqc.org/journal_reviews_2025
----------------------------------------------
𝗣𝗿𝗶𝗺𝗮𝗿𝘆 𝘀𝗼𝘂𝗿𝗰𝗲: https://bit.ly/4lHlxv7
𝗜𝗡𝗔𝗔𝗤𝗖 𝗹𝗶𝗯𝗿𝗮𝗿𝘆: https://bit.ly/4nV6BLv

02/09/2025

𝐀𝐭𝐡𝐞𝐫𝐨𝐠𝐞𝐧𝐢𝐜 𝐋𝐨𝐰-𝐃𝐞𝐧𝐬𝐢𝐭𝐲 𝐋𝐢𝐩𝐨𝐩𝐫𝐨𝐭𝐞𝐢𝐧 𝐚𝐧𝐝 𝐂𝐚𝐫𝐝𝐢𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐑𝐢𝐬𝐤
In summary, a panel of biomarkers related to LDL atherogenicity can help predict future ischemic events. An atheroprotective diet and increased physical activity could improve LDL oxidation. OxLDL has emerged as a target for immunomodulatory anti-atherosclerosis therapy, and the delivery of LDL-based nanocarriers holds promise for both imaging and therapeutics.

( )

► 𝐎𝐫𝐢𝐠𝐢𝐧𝐚𝐥 𝐬𝐨𝐮𝐫𝐜𝐞: Hernando-Redondo, J; Niño, OC; Montse F. Atherogenic low-density lipoprotein and cardiovascular risk. Current Opinion in Lipidology 36(1): p 8-13, February 2025. | DOI: 10.1097/MOL.0000000000000963
► 𝗦𝗲𝗰𝗼𝗻𝗱𝗮𝗿𝘆 𝘀𝗼𝘂𝗿𝗰𝗲: https://www.inaaqc.org/2025_asobat

02/09/2025

𝐋𝐢𝐩𝐨𝐩𝐫𝐨𝐭𝐞í𝐧𝐚 𝐚𝐭𝐞𝐫𝐨𝐠é𝐧𝐢𝐜𝐚 𝐝𝐞 𝐛𝐚𝐣𝐚 𝐝𝐞𝐧𝐬𝐢𝐝𝐚𝐝 𝐲 𝐫𝐢𝐞𝐬𝐠𝐨 𝐜𝐚𝐫𝐝𝐢𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫
En resumen, un panel de biomarcadores relacionados con la aterogenicidad de las LDL puede ayudar a predecir futuros eventos isquémicos. Una dieta ateroprotectora y una mayor actividad física podrían mejorar la oxidación de las LDL. La oxLDL se ha convertido en un objetivo para la terapia antiateroesclerosis inmunomoduladora y la administración de nanotransportadores basados en LDL es prometedora tanto para la imagenología como para la terapéutica

( )

► 𝐎𝐫𝐢𝐠𝐢𝐧𝐚𝐥 𝐬𝐨𝐮𝐫𝐜𝐞: Hernando-Redondo, J; Niño, OC; Montse F. Atherogenic low-density lipoprotein and cardiovascular risk. Current Opinion in Lipidology 36(1): p 8-13, February 2025. | DOI: 10.1097/MOL.0000000000000963
► 𝗦𝗲𝗰𝗼𝗻𝗱𝗮𝗿𝘆 𝘀𝗼𝘂𝗿𝗰𝗲: https://www.inaaqc.org/2025_asobat

02/09/2025

𝗖𝗘𝗢 𝘀𝗮𝘆𝘀 𝗶𝗻𝗱𝗶𝘃𝗶𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝘆, 𝗻𝗼𝘁 𝗶𝗻𝗰𝗹𝘂𝘀𝗶𝗼𝗻, 𝗶𝘀 𝘁𝗵𝗲 𝗴𝗼𝗮𝗹
Leaders must be at the forefront of change, discarding their own "beloved" stories and biases and committing to becoming "indivisible" -- seeking the fulfillment of everyone without regard to perceived differences, writes Denise Hamilton, the founder and CEO of WatchHerWork. "There is no 10-second solution for 10-generation problems. We must find and cultivate a well of patience and a commitment that can withstand challenges when they inevitably come," Hamilton writes.

&

► 𝗦𝗼𝘂𝗿𝗰𝗲: https://nextbigideaclub.com/magazine/diversity-expert-inclusivity-low-bar-indivisibility-real-aim-bookbite/48114/
-------------------------------------------
✔𝗖𝗔𝗟𝗘𝗡𝗗𝗔𝗥: https://www.inaaqc.org/calendar_2025

02/09/2025

𝗘𝗹 𝗱𝗶𝗿𝗲𝗰𝘁𝗼𝗿 𝗲𝗷𝗲𝗰𝘂𝘁𝗶𝘃𝗼 𝗮𝗳𝗶𝗿𝗺𝗮 𝗾𝘂𝗲 𝗲𝗹 𝗼𝗯𝗷𝗲𝘁𝗶𝘃𝗼 𝗲𝘀 𝗹𝗮 𝗶𝗻𝗱𝗶𝘃𝗶𝘀𝗶𝗯𝗶𝗹𝗶𝗱𝗮𝗱, 𝗻𝗼 𝗹𝗮 𝗶𝗻𝗰𝗹𝘂𝘀𝗶ó𝗻.
Los líderes deben estar a la vanguardia del cambio, descartando sus propias historias y prejuicios favoritos y comprometiéndose a ser "indivisibles", buscando la plenitud de todos sin importar las diferencias percibidas, escribe Denise Hamilton, fundadora y directora ejecutiva de WatchHerWork. "No hay una solución instantánea para los problemas de diez generaciones. Debemos encontrar y cultivar la paciencia y el compromiso necesarios para afrontar los desafíos cuando inevitablemente surjan", escribe Hamilton.

&

► 𝗦𝗼𝘂𝗿𝗰𝗲: https://nextbigideaclub.com/magazine/diversity-expert-inclusivity-low-bar-indivisibility-real-aim-bookbite/48114/
-------------------------------------------
✔𝗖𝗔𝗟𝗘𝗡𝗗𝗔𝗥: https://www.inaaqc.org/calendar_2025

02/09/2025

E-learning | 𝙄𝙉𝘼𝘼𝙌𝘾 ᴮᴼ
---------------------------------
𝙵𝙾𝚁 𝙷𝙴𝙰𝙻𝚃𝙷𝙲𝙰𝚁𝙴 𝙿𝚁𝙾𝚅𝙸𝙳𝙴𝚁𝚂 / 𝙿𝙰𝚁𝙰 𝙿𝚁𝙾𝚅𝙴𝙴𝙳𝙾𝚁𝙴𝚂 𝙳𝙴 𝚂𝙰𝙻𝚄𝙳
𝐇𝐢𝐝𝐝𝐞𝐧 𝐔𝐧𝐦𝐞𝐭 𝐍𝐞𝐞𝐝𝐬 𝐢𝐧 𝐒𝐜𝐡𝐢𝐳𝐨𝐩𝐡𝐫𝐞𝐧𝐢𝐚: 𝐖𝐡𝐚𝐭 𝐄𝐯𝐞𝐫𝐲 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐏𝐫𝐨𝐟𝐞𝐬𝐬𝐢𝐨𝐧𝐚𝐥 𝐍𝐞𝐞𝐝𝐬 𝐭𝐨 𝐊𝐧𝐨𝐰
Dive into the impact negative symptoms have on patients living with schizophrenia

🚥 𝗦𝘁𝗮𝗿𝘁 𝗮𝗰𝘁𝗶𝘃𝗶𝘁𝘆: https://www.medscape.org/viewarticle/1001571?sso=true&uac=125644CK&src=mkmcmr_driv_cust_mscpedu_250219-OUS-PCP-1001571-cta
---------------------------------
✔ 𝗘 -𝗹𝗲𝗮𝗿𝗻𝗶𝗻𝗴: https://www.inaaqc.org/e-learning

01/09/2025

𝐒𝐲𝐧𝐜𝐨𝐩𝐞 𝐦𝐞𝐜𝐡𝐚𝐧𝐢𝐬𝐦, 𝐫𝐨𝐥𝐞 𝐨𝐟 𝐚𝐦𝐛𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐁𝐏
In conclusion, the standardized 2STEPS protocol offers an easy-to-perform and time-saving diagnostic test, allowing identification of the hemodynamic mechanism of loss of consciousness in most patients with autonomic syncope. This protocol provides the necessary background for personalized mechanism-specific therapy.

( )

► 𝐎𝐫𝐢𝐠𝐢𝐧𝐚𝐥 𝐬𝐨𝐮𝐫𝐜𝐞: Groppelli A, Russo V, Parente E et al. Mechanism of syncope: role of ambulatory blood pressure monitoring and cardiovascular autonomic function assessment European Heart Journal, Volume 46, Issue 9, 1 March 2025, Pages 827–835, https://doi.org/10.1093/eurheartj/ehae907
► 𝗦𝗲𝗰𝗼𝗻𝗱𝗮𝗿𝘆 𝘀𝗼𝘂𝗿𝗰𝗲: https://www.inaaqc.org/2025_asobat

01/09/2025

𝐌𝐞𝐜𝐚𝐧𝐢𝐬𝐦𝐨 𝐝𝐞 𝐬í𝐧𝐜𝐨𝐩𝐞, 𝐩𝐚𝐩𝐞𝐥 𝐝𝐞 𝐥𝐚 𝐏𝐀 𝐚𝐦𝐛𝐮𝐥𝐚𝐭𝐨𝐫𝐢𝐚
En conclusión, el protocolo estandarizado 2STEPS ofrece una prueba diagnóstica fácil de realizar y que ahorra tiempo, permitiendo la identificación del mecanismo hemodinámico de la pérdida de conciencia en la mayoría de los pacientes con síncope autonómico. Este protocolo proporciona los antecedentes necesarios para una terapia personalizada específica del mecanismo

( )

► 𝐎𝐫𝐢𝐠𝐢𝐧𝐚𝐥 𝐬𝐨𝐮𝐫𝐜𝐞: Groppelli A, Russo V, Parente E et al. Mechanism of syncope: role of ambulatory blood pressure monitoring and cardiovascular autonomic function assessment European Heart Journal, Volume 46, Issue 9, 1 March 2025, Pages 827–835, https://doi.org/10.1093/eurheartj/ehae907
► 𝗦𝗲𝗰𝗼𝗻𝗱𝗮𝗿𝘆 𝘀𝗼𝘂𝗿𝗰𝗲: https://www.inaaqc.org/2025_asobat

𝙄𝙉𝘼𝘼𝙌𝘾 ᴮᴼ

03/09/2025

03/09/2025

03/09/2025

03/09/2025

02/09/2025

02/09/2025

02/09/2025

02/09/2025

02/09/2025

02/09/2025

01/09/2025

01/09/2025

Adres

Website

Meldingen

Contact De Praktijk

Snelkoppelingen

Delen

Type